[1] |
Liu Y, Huang J, Yu N, et al. Involvement of WNT2 in trophoblast cell behavior in preeclampsia development[J]. Cell Cycle, 2020, 19(17): 2207-2215. DOI: 10.1080/15384101.2020.1802913.
|
[2] |
|
[3] |
|
[4] |
Li XL, Guo PL, Xue Y, et al. An analysis of the differences between early and late preeclampsia with severe hypertension[J]. Pregnancy Hypertens, 2016, 6(1): 47-52. DOI: 10.1016/j.preghy.2015.12.003.
|
[5] |
Barton JR, Woelkers DA, Newman RB, et al. Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study[J]. Am J Obstet Gynecol, 2020, 222(3): 259.e1-259.e11. DOI: 10.1016/j.ajog.2019.09.003.
|
[6] |
Roberge S, Nicolaides K, Demers S, et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and Meta-analysis[J]. Am J Obstet Gynecol, 2017, 216(2): 110-120.e6. DOI: 10.1016/j.ajog.2016.09.076.
|
[7] |
Shah DA, Khalil RA. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia[J]. Biochem Pharmacol, 2015, 95(4): 211-226. DOI: 10.1016/j.bcp.2015.04.012.
|
[8] |
Pourghassem Gargari B, Pourteymour Fard Tabrizi F, Sadien B, et al. Vitamin D status is related to oxidative stress but not high-sensitive C-reactive protein in women with pre-eclampsia[J]. Gynecol Obstet Invest, 2016, 81(4): 308-314. DOI: 10.1159/000441781.
|
[9] |
Lewis RA, Durrington C, Condliffe R, et al. BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?[J]. Eur Respir Rev, 2020, 29(156): 200009. DOI: 10.1183/16000617.0009-2020.
|
[10] |
Asferg CL, Andersen UB, Linneberg A, et al. Serum B-type natriuretic peptide does not increase with higher systolic blood pressure in obese men despite evidence of blood pressure-related increases in left ventricular mass and filling pressure[J]. Peptides, 2020, 134: 170390. DOI: 10.1016/j.peptides.2020.170390.
|
[11] |
谢幸,孔北华. 妇产科学[M]. 9版. 北京:人民卫生出版社,2018: 154-155.
|
[12] |
Peterson JA, Sandgren K, Levine LD. Severe preterm preeclampsia: an examination of outcomes by race[J]. Am J Obstet Gynecol MFM, 2020, 2(4): 100181. DOI: 10.1016/j.ajogmf.2020.100181.
|
[13] |
Mirkovic L, Tulic I, Stankovic S, et al. Prediction of adverse maternal outcomes of early severe preeclampsia[J]. Pregnancy Hypertens, 2020, 22: 144-150. DOI: 10.1016/j.preghy.2020.09.009.
|
[14] |
Myatt L. The prediction of preeclampsia: the way forward[J]. Am J Obstet Gynecol, 2020, S0002-9378(20)31277-1. DOI: 10.1016/j.ajog.2020.10.047.
|
[15] |
Rana S, Burke SD, Karumanchi SA. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders[J]. Am J Obstet Gynecol, 2020, S0002-9378(20)31196-0. DOI: 10.1016/j.ajog.2020.10.022. Epub ahead of print. PMID: 33096092.
|
[16] |
Afshani N, Moustaqim-Barrette A, Biccard BM, et al. Utility of B-type natriuretic peptides in preeclampsia: a systematic review[J]. Int J Obstet Anesth, 2013, 22(2): 96-103. DOI: 10.1016/j.ijoa.2012.11.001.
|
[17] |
Borges V, Zanati SG, Peraçoli M,et al. Maternal left ventricular hypertrophy and diastolic dysfunction and brain natriuretic peptide concentration in early- and late-onset pre-eclampsia[J]. Ultrasound Obstet Gynecol, 2018, 51(4): 519-523. DOI: 10.1002/uog.17495.
|
[18] |
Macheret F, Heublein D, Costello-Boerrigter LC, et al. Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP[J]. J Am Coll Cardiol, 2012, 60(16): 1558-1565. DOI: 10.1016/j.jacc.2012.05.049.
|
[19] |
Clerico A, Giannoni A, Vittorini S, et al. Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones[J]. Am J Physiol Heart Circ Physiol, 2011, 301(1): H12-H20. DOI: 10.1152/ajpheart.00226.2011.
|
[20] |
Kuhn M. Molecular physiology of membrane guanylyl cyclase receptors[J]. Physiol Rev, 2016, 96(2): 751-804. DOI: 10.1152/physrev.00022.2015.
|
[21] |
Kato J. Natriuretic peptides and neprilysin inhibition in hypertension and hypertensive organ damage[J]. Peptides, 2020, 132: 170352. DOI: 10.1016/j.peptides.2020.170352.
|
[22] |
Tsuruda T, Boerrigter G, Huntley BK, et al. Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases[J]. Circ Res, 2002, 91(12): 1127-1134. DOI: 10.1161/01.res.0000046234.73401.70.
|
[23] |
Kuwahara K. The natriuretic peptide system in heart failure: diagnostic and therapeutic implications[J]. Pharmacol Ther, 2021, 227: 107863. DOI: 10.1016/j.pharmthera.2021.107863.
|
[24] |
Kumari M, Kovach T, Sheehy B, et al. Circulating NT-proBNP but not soluble corin levels were associated with preeclampsia in pregnancy-associated hypertension[J]. Clin Biochem, 2019, 67: 12-15. DOI: 10.1016/j.clinbiochem.2019.03.005.
|
[25] |
Sandrim VC, Palei AC, Sertório JT, et al. Alterations in cyclic GMP levels in preeclampsia may reflect increased B-type natriuretic peptide levels and not impaired nitric oxide activity[J]. Clin Biochem, 2011, 44(12): 1012-1014. DOI: 10.1016/j.clinbiochem.2011.05.026.
|
[26] |
|
[27] |
|
[28] |
Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J]. N Engl J Med, 2002, 347(3): 161-167. DOI: 10.1056/NEJMoa020233.
|